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Abstract
Background & Aims: Ghrelin, a gut hormone with pleiotropic effects, may
act as a protective signal in parenchymal cells. We investigated the protec-
tive effects of ghrelin on hepatocytes after ischaemia/reperfusion (I/
R). Methods: Hepatic injury was assessed by measurement of plasma alanine
aminotransferase (ALT) and lactate dehydrogenase (LDH), histological anal-
ysis, and TUNEL assay. Effects of exogenous ghrelin and ghrelin receptor
gene deletion on I/R induced injury of liver were evaluated. Results: Ischae-
mia/reperfusion induced a profound injury to hepatocytes. This was accom-
panied by elevations in plasma ALT and LDH. Pretreatment with ghrelin
significantly reduced elevations in plasma ALT and LDH, and attenuated tis-
sue damage induced by hepatic I/R in mice. Hepatic injury induced by I/R
was more pronounced in ghrelin receptor gene null mice. Ghrelin adminis-
tration blocked the up-regulation of AMP-activated protein kinase (AMPK)
activity induced by hepatic I/R. Conclusions: This study demonstrates that
ghrelin contributes to the cytoprotection during hepatic I/R.
Hepatic ischaemia/reperfusion injury (HIRI) may occur
in association with conditions ranging from liver resec-
tion, liver transplantation or generalized shock. The
consequences of ischaemia/reperfusion injury vary
widely from transient liver dysfunction, hepatic failure
and the systemic inflammatory response syndrome with
multiple organ failure (1, 2). For liver transplantation,
hepatic ischaemia/reperfusion injury is a major factor in
development of primary graft dysfunction and primary
nonfunction, occurring in 10–30% and 5% of allografts
respectively (3, 4). About 80% of allograft re-transplan-
tation during the first week after surgery is attributable
to primary nonfunction. Limiting the adverse effects of
ischaemia/reperfusion injury is therefore a critical strat-
egy in improving the success of liver transplantation.
The search for effective prevention of hepatic ischae-
mia/reperfusion injury has focused mainly on anti-
inflammation strategies. While many investigators have
demonstrated complex interactions between inflamma-
tory mediators and hepatic injury induced by ischaemia
and reperfusion, clinically useful anti-inflammatory
agents are still lacking (5–7). An alternative approach
suggests shifting focus from inflammatory antagonism
to reduction of hepatic cell damage. As one example,
activation of AMP-activated proteinkinase (AMPK), an
intracellular fuel sensing molecule that protects from
damage caused by depletion of ATP, significantly
reduced hepatic injury induced by ischaemia and reper-
fusion (8).
Ghrelin, a gastric 28 amino acids peptide hormone, is
the endogenous ligand for the ghrelin receptor (9), also
named the growth hormone secretagogue receptor 1a
(GHSR1a). Originally identified as a growth hormone
secretagogue, ghrelin is now recognized to express a
wide variety of physiological functions, including stimu-
lation of food intake (10), regulation of energy homeo-
stasis (10), gastrokinesis (11), vasodilatation (12) and
modulation of immunity (13). Cytoprotective effects of
ghrelin have been reported in pancreas (14), heart (12),
gastrointestinal tract and liver (15). In liver, ghrelin has
been reported to protect hepatocytes from acute injury
induced by toxic chemical substances such as carbon
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tetrachloride (16, 17), acetaminophen (15) and endo-
toxin lipopolysaccharide (18). Ghrelin has also been
reported to ameliorate chronic injury evoked by hepati-
tis infection (19), inflammation (18, 20), oxidative stress
(20, 21), biliary obstruction (20) or steatosis (21). These
observations suggest that ghrelin can be protective for
hepatocytes. We hypothesized that ghrelin may protect
the liver from damage induced by hepatic ischaemia-
reperfusion injury.
We report that administration of exogenous ghrelin
significantly reduced liver injury following ischaemia/
reperfusion as measured by plasma hepatic enzymes and
histological changes such as inflammatory cell infiltra-
tion, hepatocyte ballooning and/or swelling, hepatocyte
apoptosis and tissue necrosis. Deletion of ghrelin recep-
tors exacerbated liver injury in this model.
Material and methods
Materials
Ghrelin was from Phoenix Pharmaceuticals, Inc. (Bur-
lingame, CA, USA). Aprotinin was purchased from
Amersham Biosciences (Pittsburgh, PA, USA). Rabbit
anti-phospho-AMPKa (Thr172) and rabbit anti-
AMPKa antibodies were from Cell Signalling Technol-
ogy (Beverly, MA, USA). Mouse anti-b-actin was
purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA, USA). IRDye-conjugated affinity purified
anti-rabbit and anti-mouse IgGs were purchased from
Rockland (Gilbertsville, PA, USA). Alanine aminotrans-
ferase (ALT) and lactate dehydrogenase (LDH) com-
mercial kits were purchased from NJJC Bio Inc.
(Nanjing, China). In situ cell death detection kit, POD
was purchased from Roche Diagnostics GmbH (Roche,
Mannheim, Germany).
Animals
Twelve-week-old male C57BL/6J mice, ghrelin receptor
(GHSR1a) gene knockout mice and their wild-type
littermates were used. GHSR1a gene knockout mice in
which exon 1 and exon 2 were deleted were obtained
from the Shanghai Research Center for Biomodel
Organisms (22). Mice were housed in standard plastic
rodent cages and maintained at a regulated environment
(24°C, 12-h light, 12-h dark cycle with lights on at
07:00 hours). Regular chow and water were available ad
libitum unless specified otherwise.
Ethical approval
The animals used in this study were handled in accor-
dance with the Guide for the Care and Use of Labora-
tory Animals published by the US National Institutes of
Health (NIH publication no. 85-23, revised 1996), and
all the experimental protocols were approved by the
Animal Care and Use Committee of Peking University.
Hepatic ischaemia/reperfusion (I/R) procedures
All mice were anaesthetized by intraperitoneal injec-
tion of pentobarbital at a dose of 60 mg/kg body-
weight. The liver was exposed by midline laparotomy
and the hepatic artery and the portal vein were
clamped using an atraumatic vascular clip. This pro-
cedure has been reported to cause segmental hepatic
ischaemia and to prevent mesenteric venous conges-
tion by allowing portal decompression throughout the
right and caudate lobes of the liver. Blood flow was
interrupted for 45 min to induce hepatic ischaemia
and reflow initiated by removal of the vascular clip to
allow reperfusion for 3 h.
Experimental designs
Protocol 1: Effects of exogenous ghrelin on hepatic I/R
injury. Thirty C57BL/6 mice were equally divided into
three experimental groups: (i) control sham-operated
group; (ii) I/R+ vehicle group; and (iii) I/R+ ghrelin
group. Ghrelin at a dose of 50 lg/kg body weight was
administrated intravenously via tail vein injection twice:
at 20 min before ischaemia and at 15 min before reper-
fusion. The sham-operated and I/R groups received
equal volumes of normal saline.
Protocol 2: Effects of endogenous ghrelin on hepatic
I/R injury. The ghrelin receptor gene knockout mice
(GHSR1a/) and wild-type littermates (GHSR1a+/+)
were randomly divided into sham-operated and hepatic
I/R groups. Hepatic ischaemia/reperfusion was per-
formed as described above.
Both experiments in protocol 1 and protocol 2 were
repeated three times.
Measurements of hepatic enzymes
Blood samples were transcardially collected after anaes-
thesia in the presence of aprotinin (2 lg/ml) and EDTA
(1 mg/ml). Plasma was stored at 70°C before use.
ALT and LDH were measured using commercial kits
from NJJC Bio Inc. according to the manufacturer’s
instructions.
Histological examination
Liver samples were harvested, fixed in 4% paraformalde-
hyde, paraffin-embedded, cut into 6 lm sections and
stained with haematoxylin-eosin according to standard
procedures. Tissue sections were examined for hepatic
injury in a double blind manner by experienced pathol-
ogists.
TUNEL assay
TUNEL assay was performed according to the manufac-
tures’ instruction (Roche, Mannheim, Germany). Briefly,
paraffin-embedded liver sections were de-waxed, rehy-
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drated and rinsed in PBS, followed by treatment with 3%
H2O2 in methanol to quench the endogenous hydrogen
peroxidase. Tissue sections were then treated with 20
lg/ml proteinase K at room temperature for 15 min, fol-
lowed by the incubation with TUNEL reaction mixture at
37°C in a humidified atmosphere for 1 h. After washing
in PBS three times, tissue sections were incubated with
converter-POD (horseradish peroxidase) at 37°C in a
humidified chamber for 30 min. Finally, DAB substrate
was added to visualize the apoptotic signal.
Western blot analysis
Liver tissue was isolated and then homogenized in lysis
buffer. Proteins were subjected to SDS-PAGE with a
10% running gel, and then transferred to a polyvinylid-
ene fluoride membrane. Membranes were incubated for
1 h at room temperature with 5% fat-free milk in Tris
buffered saline containing Tween 20, followed by incu-
bation overnight at 4°C with primary antibodies.
Specific reaction was detected using IRDye-conjugated
second antibody and visualized using an Odyssey
infrared imaging system (LI-COR Biosciences, Lincoln,
NE, USA).
Statistical analysis
Data were expressed as mean ± SEM and analysed by
one-way ANOVA followed by Bonferroni’s post hoc test or
unpaired Student’s t-test (between two groups) as
appropriate, using GraphPad Prism software. P < 0.05
was considered significant.
Results
Effects of exogenous ghrelin on HIRI
To determine the effects of exogenous ghrelin on
hepatic ischaemia/reperfusion injury, ghrelin was
administrated 20 min and 15 min before ischaemia and
reperfusion. As shown in Fig. 1A and B, plasma ALT
and LDH levels were significantly elevated in mice with
ischaemia/reperfusion relative to control mice with
sham operation. Treatment of animals with exogenous
ghrelin significantly reduced hepatic injury. Significant
increase in levels of plasma ghrelin has been demon-
strated in mice treated with exogenous ghrelin (Figure
S1). In addition, hepatic ischaemia/reperfusion mark-
edly increased the expression of ghrelin mRNA in liver
tissue relative to the control treatment (Figure S1).
Consistent with the changes in plasma hepatic
enzymes, histological studies revealed typical ischae-
mia/reperfusion alterations including hepatocyte bal-
looning and swelling, disruption of hepatic cords,
haemorrhage, multiple areas of hepatocyte necrosis,
infiltration of inflammatory cells (Fig. 2) and signifi-
cant increase in hepatocyte apoptosis (Fig. 3). Pretreat-
ment of ghrelin significantly ameliorated the hepatic
injury induced by ischaemia/reperfusion. Hepatocyte
apoptosis and necrosis, alterations in hepatic cords,
haemorrhage and infiltration of inflammatory cells
were significantly reduced in mice pretreated with
ghrelin relative to animals in the ischaemia/reperfusion
vehicle group.
Similar protective effect of ghrelin on hepatic ischae-
mia/reperfusion injury was also observed in BALB/c
mice (Figure S2).
Effects of ghrelin receptor gene deletion on hepatic
ischaemia-reperfusion injury
To confirm that ghrelin protects hepatocytes from
injury induced by ischaemia/reperfusion, a ghrelin
receptor gene deletion mouse model (22) was used.
Under normal chow diet, hepatic ischaemia/reperfusion
significantly increased plasma ALT and LDH levels in
wild-type littermates. Significantly greater elevations in
plasma ALT and LDH levels were observed in ghrelin
receptor gene knockout mice relative to the wild-type
littermates (Fig. 4A and B).
(A) (B)
Fig. 1. Effects of exogenous ghrelin on plasma levels of hepatic enzymes after ischaemia/reperfusion. (A) Plasma levels of alanine amino-
transferase (ALT) after hepatic ischaemia/reperfusion; (B) Plasma levels of lactate dehydrogenase (LDH) after hepatic ischaemia/reperfusion;
Hepatic ischaemia/reperfusion injury (HIRI) was induced by clamping the hepatic artery and the portal vein using an atraumatic vascular clip
to interrupt blood flow for 45 min, followed by reperfusion for 3 h. Ghrelin (50 lg/kg body weight) was administrated intravenously twice:
at 20 min before ischaemia and at 15 min before reperfusion. Data are expressed as mean ± SEM; n = 10. *P < 0.05.
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(A)
(B) (C)
Fig. 2. Effects of exogenous ghrelin on histological lesions induced by hepatic ischaemia/reperfusion. (A) Amelioration of HIRI by ghrelin.
Upper panel depicts histological changes (haematoxylin-eosin staining) in lower magnification (1009), while lower panel shows the results
in higher magnification (2009) after hepatic ischaemia/reperfusion. Shown are the representative samples from 10 individual animals in each
group. (B) Decrease of liver necrosis by ghrelin. Area of liver necrosis was quantified and expressed as mean ± SEM from at least 10 animals
per group. *P < 0.05. (C) Attenuation of the infiltration of inflammatory cells by ghrelin. The number of inflammatory cells per microscopic
view (4009magnification) was counted and expressed as mean ± SEM; n = 10. *P < 0.05. Statistical significance between the HIRI vs.
sham treatment was determined by ANOVA with Bonferroni’s multiple testing. *P < 0.05.
Fig. 3. Effects of exogenous ghrelin on hepatocyte apoptosis induced by hepatic ischaemia/reperfusion. Hepatic injury was induced by
ischaemia/reperfusion and apoptosis in hepatocytes was detected by TUNEL assay. Shown are the representative pictures from at least
10 animals per group. Upper panel depicts TUNEL staining in lower magnification (2009), while lower panel shows the results in higher
magnification (4009) after hepatic ischaemia/reperfusion.
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Consistent with these observations in NCD mice,
ischaemia/reperfusion induced hepatocyte ballooning
and swelling, disrupted hepatic cords, haemorrhage,
infiltration of inflammatory cells and tissue necrosis
(Fig. 5) in wild-type littermates. A significantly greater
degree of hepatic injury was observed in GHSR1a null
mice with ischaemia/reperfusion (Fig. 5).
Similar results were observed in mice fed high-fat diet
(HFD). Both serological (Fig. 6) and histological
(Fig. 7) and apoptosis (Fig. 8) studies demonstrated
that hepatic ischaemia/reperfusion also induced a pro-
found injury to the liver tissues in mice fed HFD. A sig-
nificant severer damage of hepatic tissues was detected
in ghrelin receptor gene knockout mice fed HFD relative
to wild-type animals (Figs 6, 7 and 8).
Effects of ghrelin on AMPK
Since the AMPK has been reported to protect hepato-
cytes from injury induced by ischaemia/reperfusion (8,
23), we next examined the effects of ghrelin on the
phosphorylation of AMPKa in hepatic tissues derived
from mice. As shown in Fig. 9A, hepatic ischaemia/
reperfusion induced significant elevations in phosphory-
lation of AMPKa in mice relative to animals with sham
operation. Pretreatment of mice with ghrelin markedly
attenuated up-regulation of AMPKa phosphorylation
induced by ischaemia/reperfusion. Consistent with this
observation, ghrelin receptor gene knockout mice dem-
onstrated a significant higher level of hepatic AMPKa
phosphorylation induced by I/R injury relative to the
wild-type littermates (Fig. 9B). In addition, exogenous
ghrelin significantly reduced the phosphorylation of
hepatic AMPKa in mice fed high-fat diet (Fig. 9C).
Discussion
The major finding of this study is that ghrelin contrib-
utes to protection of hepatic tissues induced by ischae-
mia and reperfusion injury. This general conclusion is
supported by the following observations: (i) exogenous
ghrelin significantly reduces hepatic damage induced by
ischaemia/reperfusion as assayed by levels of plasma
liver enzymes, histological assessment and apoptosis
analysis of hepatic injury; (ii) in contrast, ghrelin recep-
tor gene deletion exacerbates hepatic injury induced by
ischaemia/reperfusion in mice fed NCD or HFD; and
(iii) up-regulation of AMPKa phosphorylation induced
by hepatic ischaemia/reperfusion is decreased by admin-
istration of ghrelin, while significantly increased in ghre-
lin receptor gene knockout mice. In addition, ghrelin
markedly attenuates the phosphorylation of AMPKa in
mice fed high-fat diet.
In addition to regulation of food intake and mainte-
nance of energy homeostasis (10), gut hormones also
regulate inflammatory and cytoprotective responses in a
variety of tissues (12, 13, 15). Ghrelin, a gut hormone
with pleiotropic effects, has been demonstrated to have
cytoprotective effects in parenchymal cells ranging from
pancreatic acinar cells (24), cardiomyocytes (12), gas-
trointestinal epithelia (25) to hepatocytes (19). We pro-
vide evidence in this study that ghrelin protects
hepatocytes from injury induced by ischaemia/reperfu-
sion in mice. In liver, ghrelin has been reported to be
protective for hepatocytes in both acute and chronic
injury models (15–17, 19). Our study expands this con-
cept by demonstrating a protective effect of ghrelin on
hepatic injury induced by ischaemia/reperfusion.
Importantly, we demonstrate that both exogenous and
endogenous ghrelin contribute to the protection of
hepatocytes.
Two major forms of ghrelin in the circulation have
been reported: acyl ghrelin and des-acyl ghrelin in which
the third amino acid serine is not acylated (26). Only
acyl ghrelin is able to bind and activate its receptor,
GHSR1a (9). Our data indicate that endogenous ghrelin
functions through GHSR1a for the protective effects in
liver. This notion is supported by previous studies dem-
onstrating the presence of GHSR1a in the liver (19).
Activation of GHSR1a triggers multiple intracellular
signalling pathways including phospholipase C-inositol
1,4,5-triphosphate and AMPK signalling (27, 28). It is
(A) (B)
Fig. 4. Effects of ghrelin receptor gene deletion (GHSR1a/) on plasma levels of hepatic enzymes after ischaemia/reperfusion in mice fed
normal chow diet (NCD). (A) Plasma levels of alanine aminotransferase (ALT) after hepatic ischaemia/reperfusion; (B) Plasma levels of lactate
dehydrogenase (LDH) after hepatic ischaemia/reperfusion; Data expressed as mean ± SEM; Five to eight samples were examined for each
condition. *P < 0.05.
Liver International (2014)
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 571
Qin et al. Ghrelin and liver injury
known that AMPK, a primary fuel sensor during
changes in cellular energy levels, is activated during
hepatic ischaemia (8). AMPK activation is proposed
to preserve ATP levels, to reduce lactate accumulation
during ischaemia, and therefore to reduce hepatic
injury after reperfusion (23). In this study, we have
shown that hepatic AMPK activity is regulated by
ghrelin. Ghrelin attenuates the up-regulation of AMPK
activity during ischaemia/reperfusion, while deletion
of ghrelin receptor gene significantly enhances the up-
regulation of AMPK activity during ischaemia/reperfu-
sion. In the animal fed high-fat diet, ghrelin also
inhibits the AMPK activity. All these observations sug-
gest that AMPK activity is an important signalling
(A)
(B) (C)
Fig. 5. Effects of ghrelin receptor gene deletion (GHSR1a/) on histological lesions induced by hepatic ischaemia/reperfusion in mice fed
normal chow diet (NCD). (A) Upper panel depicts histological changes (haematoxylin-eosin staining) in lower magnification (1009), while
lower panel shows the results in higher magnification (2009) after hepatic ischaemia/reperfusion. Shown are the representative samples of
5–8 animals per group. (B) Increase of liver necrosis in ghrelin receptor gene null mice fed chow diet. Area of liver necrosis was quantified
and expressed as mean ± SEM from at least 5 animals per group. *P < 0.05. (C) Infiltration of inflammatory cells. The number of inflamma-
tory cells permicroscopic view (4009magnification) was counted and expressed as mean ± SEM; n = 5–8. Statistical significance between
the HIRI vs. sham treatment, and ghrelin null mice vs. wild-type littermates was determined by ANOVA with Bonferroni’s multiple testing.
*P < 0.05.
(A) (B)
Fig. 6. Effects of ghrelin receptor gene deletion (GHSR1a/) on plasma levels of hepatic enzymes after ischaemia/reperfusion in mice fed
high-fat diet (HFD). (A) Plasma levels of alanine aminotransferase (ALT) after hepatic ischaemia/reperfusion; (B) Plasma levels of lactate
dehydrogenase (LDH) after hepatic ischaemia/reperfusion; Data expressed as mean ± SEM; Five to eight samples were examined for each
condition. *P < 0.05.
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molecule modulated by ghrelin in the hepatocytes.
However, whether ghrelin exercises its protective effect
during ischaemia/reperfusion via the AMPK signalling
pathway remains to be determined.
The underlying mechanisms of hepatic ischaemia/
reperfusion injury include induction of tissue necrosis
(29, 30), generation of reactive oxygen species (6,
31), release of proinflammatory cytokines and recruit-
ment and activation of immunocompetent cells (3,
32). Consistent with this notion, infiltration of
inflammatory cells was significantly reduced in the
ischaemia/reperfusion mice treated with ghrelin. This
observation is in line with previous studies indicating
that ghrelin attenuates both acute and chronic
(A)
(B) (C)
Fig. 7. Effect of ghrelin receptor gene deletion (GHSR1a/) on histological lesions induced by hepatic ischaemia/reperfusion in mice fed
high-fat diet (HFD). (A) Upper panel depicts histological changes (haematoxylin-eosin staining) in lower magnification (1009), while lower
panel shows the results in higher magnification (2009) after hepatic ischaemia/reperfusion. Shown are the representative samples of 5–8
animals per group. (B) Increase of liver necrosis in ghrelin receptor gene null mice fed high-fat diet. Area of liver necrosis was quantified and
expressed as mean ± SEM from at least 5 animals per group. *P < 0.05. (C) Infiltration of inflammatory cells. The number of inflammatory
cells per microscopic view (4009 magnification) was counted and expressed as mean ± SEM; n = 5–8. Statistical significance between the
HIRI vs. sham treatment, and ghrelin null mice vs. wild-type littermates was determined by ANOVA with Bonferroni’s multiple testing.
*P < 0.05.
Fig. 8. Effect of ghrelin receptor gene deletion (GHSR1a/) on hepatocyte apoptosis induced by hepatic ischaemia/reperfusion in mice
fed high-fat diet (HFD). Hepatic injury was induced by ischaemia/reperfusion and apoptosis in hepatocytes was detected by TUNEL assay.
Shown are the representative pictures from at least 5 animals per group. Upper panel depicts TUNEL staining in lower magnification (2009),
while lower panel shows the results in higher magnification (4009) after hepatic ischaemia/reperfusion.
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inflammation by reducing the infiltration of inflam-
matory cells. Whether ghrelin acts directly on hepato-
cytes or indirectly through the modulation of
inflammatory cells for its protective effect during
hepatic ischaemia/reperfusion injury deserves further
investigation.
In summary, our study demonstrates that ghrelin
reduces hepatic injury after hepatic ischaemia/reperfu-
sion. Our results suggest that ghrelin may provide a
potential therapeutic strategy for improvement of liver
function in circumstances associated with this injury.
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